English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew data validate the benefits of the BVA-100 blood volume measurement test for Medicare heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world’s leading experts in heart failure.
Tag: Heart Failure
Puzzle Medical Devices Inc. Wins TCT 2022 Shark Tank Innovation Competition
The Cardiovascular Research Foundation (CRF) is pleased to announce that Puzzle Medical Devices Inc. has won the TCT 2022 Shark Tank Innovation Competition for its novel circulatory support device that is implanted percutaneously in the abdominal aorta. The competition took place during Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier educational meeting specializing in interventional cardiovascular medicine, September 16-19 in Boston. The winner was also presented with the Jon DeHaan Foundation Award for Innovation in Cardiology.
Boosting duration, intensity & frequency of physical activity may lower heart failure risk
A six-year analysis of more than 94,000 adults in the U.K. Biobank with no history of heart failure at enrollment has found that engaging in moderate or vigorous physical activity may lower the risk of developing heart failure, according to new research published today in the American Heart Association’s flagship journal Circulation.
New Risk Score Predicts Mortality for Atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Replacement
Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR
CRF and Fogarty Innovation Announce Agenda For TCT MedTech Innovation Forum
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program is now available for the TCT MedTech Innovation Forum. The summit will be held on the first day of TCT, the annual scientific symposium of CRF, on Friday, September 16. TCT will take place September 16-19, 2022, in Boston, Massachusetts, at the Boston Convention and Exhibition Center.
COVID mRNA vaccines are safe in patients with heart failure
COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022.
Hackensack Meridian Pascack Valley Medical Group expands cardiology group with the addition of Mohammed Gibreal, M.D.
Pascack Valley Medical Group announced that Mohammed Gibreal, M.D. has joined the practice’s cardiology group. As a noninvasive cardiologist practicing in community hospitals and tertiary care medical centers, Dr. Gibreal has vast experience delivering care in inpatient and outpatient settings.
Seven Hackensack Meridian Health Medical Centers Nationally Recognized for their Commitment to Providing High-Quality Heart Failure Care
Seven Hackensack Meridian Health medical centers have received American Heart Association Get With The Guidelines® – Heart Failure Quality Achievement Awards. The awards recognize the medical centers’ commitment to improving outcomes for patients with heart failure, reducing patient readmissions and providing more healthy days at home.
Mayo Clinic Healthcare expert shares heart failure signs, risk factors people may not be aware of
Heart failure may seem like a disease of advanced age, but it can develop at any time in life. And, in many cases, it can be prevented or treated. In this expert alert, Gosia Wamil, M.D., Ph.D., a cardiologist at Mayo Clinic Healthcare in London, explains risk factors, symptoms that people may not be aware of and how heart failure is treated.
When heart-assisting implants could save a life, patients who are Black or female don’t get them as often
Black people and women with severe heart failure who might be good candidates for surgery to implant a heart-assisting device have a lower chance of actually getting that operation than white patients, or male patients, a new study finds.
Initiative Addresses Challenges of Managing Heart Failure
A pilot program at The Brookdale University Hospital and Medical Center, Brooklyn, New York — designed to help patients manage heart failure after hospital discharge — quickly improved patient adherence to their medication and treatment plan, and resulted in fewer readmissions among the initial 47 patients.
MedStar Washington Hospital Center Again Named Among Nation’s Top 50 for Heart Care
MedStar Washington Hospital Center has again achieved national ranking for Cardiology & Heart Surgery in the 2022-23 U.S. News & World Report “Best Hospitals” rankings. It moved up to No. 28, from No. 30 last year. It is the only nationally recognized heart program of its kind in the Washington metropolitan area. MedStar Washington also earned “high performing” ratings in cancer, gastroenterology & GI surgery, Urology, and in 12 common procedures and conditions.
Heart muscle scarring found in patients with hypertension are associated with worse outcomes
First-of-its-kind study by NHCS researchers shows adverse association between heart muscle scarring (also known as myocardial fibrosis) and patients with hypertension, detected non-invasively using cardiac magnetic resonance imaging (CMR).
Loss of Male Sex Chromosome Leads to Earlier Death for Men
The loss of the male sex chromosome as many men age causes the heart muscle to scar and can lead to deadly heart failure, new research from the University of Virginia School of Medicine shows.
Death of a family member may increase heart failure mortality risk
Grieving the loss of a close family member can increase stress levels, contributing to poor HF prognosis.
Adult Cancer Survivors Have Higher Risk of Cardiovascular Disease Than Those Without Cancer, Study Shows
Adult survivors of cancer have a higher risk of heart failure and other cardiovascular diseases (CVD) later in life than adults without cancer, according to results of a large study led by Johns Hopkins Medicine researchers.
Henry Ford Health Participated in Novel Clinical Trial Without In-Person Patient Involvement
DETROIT (June 22, 2022) –Henry Ford Health was part of a multi-institutional heart failure study that was launched and executed completely virtual during the COVID-19 pandemic. The novel study design could serve as a model for future research.Unlike traditional clinical trials that involve in-person clinic visits, researchers in this study engaged directly with more than 400 patients through a mobile app and secure website to collect participants’ data and other information.
Researchers identify, test novel drug that may stop heart failure progression
Researchers at The Ohio State University Wexner Medical Center and College of Medicine have developed a novel drug molecule that targets T-cells causing inflammation in heart failure patients, stopping further progression of the disease.
Uncontrolled Diabetes Can Advance Heart Failure from Early Stage to Late Stage
Among older adults with early stage — also known as preclinical — heart failure, uncontrolled diabetes can substantially increase the risk of heart failure progression, according to a new Johns Hopkins-led study.
Heart Failure Patients Unvaccinated Against COVID-19 Are Three Times More Likely to Die From It Than Boosted Heart Failure Patients
EMBARGOED UNTIL JUNE 9, 2022, 10AM EST (New York, NY – June 9, 2022) – Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus…
Long-Term Study Finds Cigarette Smoking Doubled Risk of Developing Heart Failure
The study found that participants who had stopped smoking retained a significantly increased risk of heart failure for decades after they’d stopped smoking.
Prominent Cardiac Surgeons Join UCSF’s Advanced Heart Failure Comprehensive Care Center
UC San Francisco’s Cardiovascular team is welcoming two highly regarded cardiac surgeons to its renowned program. The specialists will join the newly formed Advanced Heart Failure Comprehensive Care Center (AHF CCC).
COVID-19’s toll on global cardiac services – International Version
A major study has revealed the “global collateral damage” caused by the disruption to cardiac services from the COVID-19 pandemic.
V-Wave’s Ventura® Interatrial Shunt: One Year Follow-up from RELIEVE-HF Roll-in Arm Shows Improved Left and Right Ventricular Function in Patients with Advanced Heart Failure
V-Wave Ltd, manufacturer of the V-Wave Ventura investigational interatrial shunt device to help patients with advanced heart failure (HF), announced 12-month echocardiographic results from the open label Roll-in arm of the RELIEVE-HF pivotal clinical trial, comprising 97 NYHA Class III or ambulatory Class IV HF patients who were already on maximally tolerated guideline directed medical therapy.
Study Finds that Concurrent Tricuspid Valve Surgery and Left Ventricular Assist Device Implantation do not Appear to Lower the Incidence of Right Heart Failure
Right heart failure (RHF) continues to be a major source of morbidity and mortality following left ventricular assist device (LVAD) implantation.
First Report of Minimally Invasive Aortic Valve Replacement Using Real-Time CT Imaging in Elderly Man with Heart Failure and Blood Clot
Cardiologists from the Structural and Congenital Heart Center and Cardiac Surgeons at Hackensack Meridian Hackensack University Medical Center/Hackensack Meridian School of Medicine have reported what is believed to be the very first patient with heart failure and a blood clot to undergo a minimally invasive transcatheter aortic valve replacement using CT (computed tomography) fusion imaging, a technique that employs two different imaging modalities.
Sex Differences in Rat Heart Ventricle Function Aren’t Caused Only by Hormones
Article title: Female rats are less prone to clinical heart failure than male rats in a juvenile rat model of right ventricular pressure load Authors: Guido P.L. Bossers, Quint A.J. Hagdorn, Anne Marie C. Koop, Diederik E. van der Feen,…
Hackensack Meridian Health Seeks Disruptive Health Solutions through NJ Innovation Challenge
The Challenge seeks to reduce 30-day readmissions for: acute myocardial infarction (AMI); chronic obstructive pulmonary disease (COPD); heart failure (HF); pneumonia; coronary artery bypass graft (CABG) surgery; and elective primary total hip arthroplasty and/or total knee arthroplasty (THA/TKA).
Heart Experts Available to Discuss Approval of New Heart Drug
Today, the Food and Drug Administration (FDA) announced the approval of mavacamten, a new drug shown to provide relief to obstructive hypertrophic cardiomyopathy patients experiencing shortness of breath.
Could exercise counteract cardiotoxic chemotherapy for women with breast cancer
When you’re a breast cancer survivor, the last thing you need is another health scare. So, it’s concerning to know that up to 48 per cent of breast cancer patients will go on to fight heart disease as a direct result of chemotherapy.
Cardiologists, Cardiothoracic Surgeons Available for Expert Commentary Ahead of Upcoming Conferences
Cardiologists and cardiothoracic surgeons from the Smidt Heart Institute at Cedars-Sinai are available to discuss the latest advances in research, clinical care, transcatheter procedures and cardiothoracic surgery throughout the International Society for Heart and Lung Transplantation (ISHLT) Scientific Sessions 2022 and Heart Rhythm 2022.
Smidt Heart Institute: Annual Report Highlights
The 2022 Annual Report from the Smidt Heart Institute at Cedars-Sinai is available now, detailing the latest research and medical achievements by the expert team ranked No. 1 for cardiology and cardiac surgery in California by U.S. News & World Report.
Penn State College of Medicine receives $3 million for artificial heart research
Development of an implantable artificial heart that operates wirelessly and reliably for 10 years is the goal of an ongoing Penn State College of Medicine project.
Investigational Drug for Heart Failure has Little Impact on Exercise Tolerance
Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on their ability to exercise compared to a placebo, according to a study supported by the Duke Clinical Research Institute.
Aspirin is linked with increased risk of heart failure
Aspirin use is associated with a 26% raised risk of heart failure in people with at least one predisposing factor for the condition.
Popular heart failure drug no better than older drug in sickest patients
A new study led by researchers at Washington University School of Medicine in St. Louis suggests that a widely used heart failure drug named sacubitril/valsartan is no better than valsartan alone in patients with severe heart failure. The study also provides evidence that the treatment with valsartan may be slightly safer for patients with advanced heart failure.
New cause of inherited heart condition discovered
A UCL-led research team has identified a new gene as a cause of hypertrophic cardiomyopathy, an inherited heart condition affecting one in 500 people.
Study links free radicals to heart damage caused by cancer
A new study in animal models shows that a cancer tumor alone can lead to cardiac damage, and suggests the culprits are free radicals interacting with cells in the heart. Adding antioxidants to food consumed by fruit flies with tumors reversed the damage to their hearts.
Mount Sinai Cardiologist Leads Effort to Outline Guidance for Management of Heart Failure Patients During COVID-19 Pandemic
New scientific statement aims to establish more streamlined care to improve outcomes in this high-risk group
Drinking sufficient water could prevent heart failure
Staying well hydrated throughout life could reduce the risk of developing heart failure, according to research presented at ESC Congress 2021.
Mount Sinai Heart Earns Two Prestigious Recognitions for Heart Failure and Catherization Lab
Awards highlight highest level of quality of care
Heart Cell Protein Could Lead to New Treatments for Heart Failure and Recovery
A protein that helps regulate calcium signaling within heart cells could play a key role in preventing chronic heart failure, according to an international study led by University of Utah Health scientists. T The finding suggests that drugs and other therapeutic treatments targeting this protein could eventually help alleviate heart failure.
Heart Failure Diagnoses May Be Missed in a Primary Care Setting for Women, Black Adults
Many heart failure diagnoses may be missed in a primary care setting.
Atlantic Health System and NYU Langone Health Announce Partnership on Organ Transplantation
Two of the leading names in health care in the tri-state region, New Jersey–based Atlantic Health System and New York–based NYU Langone Health, are teaming up to give patients greater access to heart and liver transplants and the coordinated, high-quality care needed to stay healthy. The clinical affiliation will partner NYU Langone’s nationally recognized transplant program with the nationally ranked Atlantic Health System Heart Care program located at Morristown Medical Center’s Gagnon Cardiovascular Institute (Morristown, NJ) and the ground-breaking liver services at Overlook Medical Center (Summit, NJ).
UH First in Northeast Ohio to Treat Patient with Heart Failure Using Cardiac Contractility Modulation
A University Hospitals (UH) patient is the first in Northeast Ohio to undergo a new, innovative procedure called CCM® therapy.
Cardiologists at Henry Ford Are First in U.S. to Implant New Device to Treat Heart Failure, Improve Kidney Function
Cardiologists at Henry Ford Hospital are first in the U.S. and second in the world to implant a circulatory support device that is being investigated in a clinical trial for patients hospitalized with acute decompensated heart failure (ADHF) and worsening kidney function, a condition known as cardiorenal syndrome.
Fat Around the Heart Linked to Increased Risk of Heart Failure
EMBARGOED UNTIL MAY 24 2:00PM EST (New York, NY – May 24, 2021) – Having excess pericardial fat—fat around the heart—increases the risk of developing heart failure, especially in women, according to new Mount Sinai research. Women with high amounts…
Novel Rehab Program Improves Outcome for Older Heart-failure Patients, Study Finds
Heart failure (HF) – when the heart can’t pump enough blood and oxygen through the body – affects approximately 6.2 million adults in the United States and is the primary cause of hospitalization in the elderly. Unfortunately, older adults with heart failure often have poor outcomes resulting in reduced quality of life, high mortality and frequent rehospitalizations.
Study Links Delirium to Hospitalized Older Adults with Acute Heart Failure Mortality
A possible link between delirium and mortality in hospitalized older adults with acute heart failure exacerbation has been found by researchers at The University of Texas Health Science Center at Houston (UTHealth).
Study Estimates Two-Thirds of COVID-19 Hospitalizations Due to Four Conditions
A new study estimates 64% of adult COVID-19 hospitalizations in the U.S. may have been prevented if there were less obesity, hypertension, diabetes, and heart failure. The model suggests notable differences by age and race/ethnicity in COVID-19 hospitalizations related to these conditions.